Concept information
Terme préférentiel
BBIBP-CorV
Définition
- BBIBP-CorV is one of two inactivated virus COVID-19 vaccines being developed by Sinopharm. As of December 2020, it is in Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. By November, nearly one million people had taken the vaccine through China's emergency use program. (Wikipédia)
Concept générique
Créateur
- Patricia Fener
Traductions
-
français
URI
http://data.loterre.fr/ark:/67375/C0X-ZZSTX1BQ-P
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}